MED17 and Cerebral atrophy: In common with other patients reported with variants in MED11, MED17, MED20, and MED27, we demonstrate that MED29 biallelic variants cause progressive microcephaly, intellectual disability, spasticity, and cerebral atrophy, in addition to the striking pontocerebellar hypoplasia with likely progressive basal ganglia involvement.